Concepedia

Author

Alessandra Oggero

University of Turin

Also Known As

A OGGERO, A Oggero, A. Oggero, Alessandra Oggero, Carolina Nicoletti

20

Publications

580

Citations

12

H-Index

30

Concepts

All Affiliations

University of TurinOspedale San Luigi GonzagaAzienda Ospedaliero Universitaria San Giovanni BattistaAzienda Ospedaliera Sant’Antonio Abate di Gallarate
AO

About

Alessandra Oggero is an author at University of Turin specializing in medicine, multiple sclerosis, and autoimmune disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

228

2

Business

1

1

165

3

Engineering

1

1

165

4

Public Health

1

1

14

5

Civil Engineering

1

1

165

Alessandra Oggero

×

14

Publications

557

Citations

12

H-Index

YearCitations

A survey of accidents occurring during the transport of hazardous substances by road and rail

Alessandra Oggero, Miguel Muñoz, Eulàlia Planas,

Journal of Hazardous Materials

2005

165

Autoimmune events during interferon beta-1b treatment for multiple sclerosis

Luca Durelli, Bruno Ferrero, Alessandra Oggero,

Journal of the Neurological Sciences

1999

89

Liver and thyroid function and autoimmunity during interferon-β1b treatment for MS

Luca Durelli, Bruno Ferrero, Alessandra Oggero,

Neurology

2001

55

Thyroid Function and Autoimmunity during Interferon β-1b Treatment: A Multicenter Prospective Study

Luca Durelli, Bruno Ferrero, Alessandra Oggero,

The Journal of Clinical Endocrinology & Metabolism

2001

47

Interferon treatment for multiple sclerosis

Luca Durelli, Maria Roberta Bongioanni, Bruno Ferrero,

Neurology

1998

41

Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study

Luca Durelli, Alessandra Oggero, E. Verdun,

Journal of the Neurological Sciences

2001

35

Autoantibodies in Multiple Sclerosis Patients Before and During IFN- <i>β</i> 1b Treatment: Are They Correlated with the Occurrence of Autoimmune Diseases?

E. Verdun, G. Isoardo, Alessandra Oggero,

Journal of Interferon & Cytokine Research

2002

31

Long term recombinant interferon alpha treatment in MS with special emphasis to side effects

Luca Durelli, MR Bongioanni, Bruno Ferrero,

Multiple Sclerosis Journal

1996

18

Systemic high-dose recombinant-alpha-2a-interferon therapy modulates lymphokine production in multiple sclerosis

Maria Roberta Bongioanni, Luca Durelli, Bruno Ferrero,

Journal of the Neurological Sciences

1996

15

Quality of life and patient preferences: identification of subgroups of multiple sclerosis patients

Rosalba Rosato, Silvia Testa, Alessandra Oggero,

Quality of Life Research

2015

14

Page 1